[Effects of a heterologous immune serum against bone marrow cells of the mouse].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000937:Antigen-Antibody Reactions; D001402:B-Lymphocytes / Q000276:immunology; D001853:Bone Marrow / Q000276:immunology*; D001854:Bone Marrow Cells; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection / Q000187:drug effects; D006087:Graft vs Host Reaction / Q000187:drug effects; D006168:Guinea Pigs; D006382:Hemadsorption; D006462:Hemolytic Plaque Technique; D006649:Histocompatibility Antigens; D007106:Immune Sera / Q000008:administration & dosage / Q000494:pharmacology*; D007114:Immunization; D008198:Lymph Nodes / Q000276:immunology; D051379:Mice; D008815:Mice, Inbred Strains; D011817:Rabbits; D013950:Thymus Gland / Q000276:immunology; D014181:Transplantation Immunology / Q000187:drug effects; D014182:Transplantation, Autologous
D006649:Histocompatibility Antigens; D007106:Immune Sera; D003165:Complement System Proteins
Uber einige Wirkungseigenschaften eines heterologen Immunserums gegen Knochenmarkzellen der Maus